Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
Zhejiang Huakang Pharmaceutical Co., Ltd. announced an investor briefing regarding the termination of a major asset restructuring. The meeting is scheduled to take place online at the Shanghai Stock Exchange's Roadshow Center. The company aims to enhance communication with investors by addressing common concerns during the session. Participants will include key executives from the company, and investors can submit questions prior to the meeting.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Holding the Investor Briefing on Terminating Major Asset Restructuring
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Zhejiang Huakang Pharmaceutical Co., Ltd. on 6ix
Follow Zhejiang Huakang Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huakang Pharmaceutical